Pfizer settles Chantix suits for $273 million

Suits claimed company’s smoking-cessation drug causes injuries and raises risk of suicide

Pfizer Inc. has paid up big time to settle lawsuits claiming its smoking-cessation drug Chantix caused serious harm.

In its annual report filed on Feb. 28 with the Securities and Exchange Commission (SEC), the pharmaceutical company said it has agreed to settle roughly 80 percent of the more than 2,700 suits claiming Chantix caused suicide and other injuries. The agreements cost Pfizer $273 million last year, and the company has set aside $15 million to resolve all remaining claims in the U.S., according to the report.

Ashley Post

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.